Sanara MedTech (SMTI) EBITDA Margin (2010 - 2026)
Sanara MedTech (SMTI) reported EBITDA Margin of 15.33% for Q1 2026, up 383.0% on a YoY basis from 3.17% in Q1 2025, and down 9.96% quarter-over-quarter from 17.03% in Q4 2025.
Sanara MedTech (SMTI) EBITDA Margin (2010 - 2026) Analysis & Trends
Sanara MedTech has reported EBITDA Margin for 16 years, with the latest figure at 15.33% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 383.0% year-over-year to 15.33%; the trailing twelve-month figure through Mar 2026 stood at 15.37% (up 456.0% YoY), and the FY2025 full-year result was 16.5%, up 594.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 15.33%, down from 17.03% in the prior quarter.
- The five-year high for EBITDA Margin was 43.41% in Q4 2022, with the low at 34.36% in Q1 2022.
- Historically, EBITDA Margin has averaged 3.0% across 5 years, with a median of 2.94% in 2024.
- The largest YoY upside for EBITDA Margin was 3208 bps in 2023 against a maximum downside of 4088 bps in 2023.
- Sanara MedTech's EBITDA Margin stood at 43.41% in 2022, then slumped by 94 bps to 2.54% in 2023, then surged by 507 bps to 15.41% in 2024, then advanced by 11 bps to 17.03% in 2025, then decreased by 10 bps to 15.33% in 2026.
- The last three EBITDA Margin figures came in at 15.33% (Q1 2026), 17.03% (Q4 2025), and 18.64% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 1.63% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -9.90% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Sanara MedTech | 196.68 Mn | 183.08 Mn | 25.87 Mn | 15.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.33% |
| Dec 31, 2025 | 17.03% |
| Sep 30, 2025 | 18.64% |
| Jun 30, 2025 | 10.32% |
| Mar 31, 2025 | 11.50% |
| Dec 31, 2024 | 15.41% |
| Sep 30, 2024 | 11.83% |
| Jun 30, 2024 | 2.94% |
| Mar 31, 2024 | 1.68% |
| Dec 31, 2023 | 2.54% |
| Sep 30, 2023 | 1.66% |
| Jun 30, 2023 | -1.88% |
| Mar 31, 2023 | -7.14% |
| Dec 31, 2022 | 43.41% |
| Sep 30, 2022 | -23.96% |
| Jun 30, 2022 | -33.95% |
| Mar 31, 2022 | -34.36% |
| Dec 31, 2021 | 34.03% |
| Sep 30, 2021 | -30.25% |
| Jun 30, 2021 | -16.07% |